Search

everythinglearnresearchcommunity

for

Search:↓

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

Olive oil compounds may help prevent cancer in animals, but human results are mixed.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Patients with skin cancer on the scalp and ear in Mexico have specific features and results from their treatments.

A pancreatic tumor caused high glucagon levels and symptoms, but treatment reduced glucagon and shrank liver tumors.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

A horse in Brazil with skin and gut issues was diagnosed with a severe disease and had to be euthanized.

A man's rare tumor caused unusual nerve-related symptoms that improved after surgery.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

Mohs micrographic surgery is effective for early-stage non-melanoma skin cancers on the lips, with basal cell carcinoma more common on the upper cutaneous lip and squamous cell carcinoma more common on the lower vermilion lip.

Cancer patients with COVID-19 face higher risks due to possible additional infections.

The combination treatment showed a higher response rate but no significant survival benefits.

Seborrheic keratosis is a common, harmless skin growth that can look like cancer, so it may need a biopsy.

Two patients with Cronkhite-Canada syndrome achieved remission after treatment.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

New treatments targeting genetic mutations in lung cancer are needed for better outcomes.

Insurers opposed ASCO's recommendation for a single cancer care pathway program.

Porocarcinoma generally has low rates of recurrence, spread to lymph nodes, and death.

A man with a rare scalp cancer was successfully treated, highlighting the need for early management to prevent spread and complications.

Erlotinib can cause hair loss and texture changes.

Late dumping syndrome after fundoplication can be diagnosed with an oral glucose tolerance test and managed with diet changes.

Eosinophilic cystitis is often misdiagnosed, but accurate diagnosis and treatment improve outcomes.

A man with a rare adrenal cancer showed unusual symptoms and died four months after diagnosis.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Docetaxel is effective against various cancers but mainly causes neutropenia.